UBS keeps EUR 300 target for Sartorius stock before results
Published on 10/20/2026 at 10:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSSignals before quarterly results
- UBS maintained its EUR 300.00 target and Buy rating for Sartorius on October 15, 2026.
- Second-quarter 2026 revenue reached EUR 911.8 million, up 3.10 percent year over year.
- Sartorius stock trades at EUR 262.30 at 10:34 a.m. CEST at Lang & Schwarz on October 20, 2026, 0.73 percent above the Xetra close of October 19, 2026.
- Third-quarter results are scheduled for October 21, 2026, followed by the conference call on October 22, 2026.
Sartorius (ISIN DE0007165631) trades at EUR 262.30 at Lang & Schwarz on October 20, 2026, 0.73 percent above the Xetra close of October 19, 2026. UBS reiterated its Buy rating and EUR 300.00 target on October 15, 2026, according to MarketScreener.
Results are the immediate catalyst
Sartorius is approaching its third-quarter update with a target that sits EUR 37.70 above the Lang & Schwarz price. That implies 14.37 percent upside from the quoted price to UBS's target, although the analyst note does not establish a new target level.
For the second quarter of 2026, revenue reached EUR 911.8 million, up 3.10 percent from the second quarter of 2025, while net income rose to EUR 65.9 million from EUR 32.5 million. Simply Wall St reported the figures and said revenue missed analyst estimates by 1.00 percent.
What does EUR 300 mean?
The analyst range remains wide. RBC kept a Sector Perform rating and a EUR 220.00 target on October 6, 2026, while JPMorgan maintained Overweight with a EUR 295.00 target on October 12, 2026, according to MarketScreener and t-online.
Three analyst moves since October 6
On October 6, 2026, RBC set its target at EUR 220.00; on October 12, 2026, JPMorgan retained EUR 295.00; and on October 15, 2026, UBS retained EUR 300.00. The sequence gives investors a clear pre-results spread of EUR 80.00 between the lowest and highest cited targets.
Two dates for the results
MarketScreener lists the third-quarter earnings release for October 21, 2026. Sartorius's investor-relations page schedules the 9M 2026 results conference call for October 22, 2026 at 1:00 p.m. CEST through Sartorius.
Stock remains below yearly high
The EUR 262.30 quote is EUR 9.60 below the 52-week high of EUR 271.90 and EUR 63.80 above the 52-week low of EUR 198.50. Market capitalization is EUR 16.2 billion, based on the latest structured market data.
The further course of trading is shown by the continuously updated real-time quote of Sartorius stock.
Sartorius stock facts
- Company: Sartorius AG
- ISIN: DE0007165631
- Ticker: SRT3
- Primary exchange: Xetra
- Price Lang & Schwarz (as of October 20, 2026, 10:34 a.m. CEST): EUR 262.30
- Change versus Xetra close: plus 0.73 percent
- Xetra close (October 19, 2026): EUR 260.40
- Market capitalization: EUR 16.2 billion (as of October 20, 2026)
- 52-week range: EUR 198.50-271.90 (as of October 20, 2026)
- Sector / Industry: Healthcare / Medical Instruments and Supplies
Market context: Market report DAX.
